In utero fetal death;Morts fœtales in utero

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 43, Issue 10, 2014, Pages 883-907

  Quibel, T ^a   Bultez, T ^a   Nizard, J ^c,d   Subtil, D ^e   Huchon, C ^a,b   Rozenberg, P ^a,b  

^a CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^b Risques Cliniques et Securite en Sante des Femmes et en Sante Perinatale   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d UNIVERSITÉ PIERRE ET MARIE CURIE   (France)

^e UNIV LILLE   (France)

Author keywords

Antepartum fetaldeath; Classification ofstillbirth; Fetal autopsy; fetal loss; Intrapartum fetaldeath; Intrauterine fetaldeath; Lactation inhibition; Stillbirth

Indexed keywords

CABERGOLINE;

ARTICLE; AUTOPSY; CHROMOSOME ABERRATION; CLINICAL EVALUATION; CONGENITAL MALFORMATION; DIABETES MELLITUS; FETUS DEATH; FRANCE; HUMAN; HYPERTENSION; LACTATION INHIBITION; MATERNAL AGE; MATERNAL DISEASE; MATERNAL OBESITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREGNANCY; PREVALENCE; PREVENTION STUDY; RISK FACTOR; SMALL FOR DATE INFANT; SMOKING; SOLUTIO PLACENTAE; ETIOLOGY; FEMALE; PREVENTION AND CONTROL;

FEMALE; FETAL DEATH; HUMANS; PREGNANCY;

EID: 84923047552     PISSN: 03682315     EISSN: 17730430     Source Type: Journal    
DOI: 10.1016/j.jgyn.2014.09.018     Document Type: Article

References (125)

1. WHO. ICD-10: International statistical classification ofdiseases and related health problems-instruction manual. Geneva, Switzerland: World Health Organization; 2004.
2. Stanton C, Lawn JE, Rahman H, Hill K. Stillbirth rates: delivering estimates in 190 countries. Lancet 2006; 367: 1487-94.
3. Flenady V, Koopmans L, Middleton P, Frøen JF, Smith GC, Gibbons K, et al. Major risk factors for stillbirth in highincomecountries: a systematic review and meta-analysis. Lancet2011; 377: 1331-40.
4. Getahun D, Ananth CV, Kinzler WL. Risk factors for antepar-tum and intrapartum stillbirth: a population-based study. AmJ Obstet Gynecol 2007; 6: 499-507.
5. Smith GC, Shah I, White IR, Pell JP, Crossley JA, Dobbie R. Maternal and biochemical predictors of antepartum stillbirthamong nulliparous women in relation to gestational age offetal death. BJOG 2007; 4: 705-14.
6. Villamor E, Cnattingius S. Interpregnancy weight change andrisk of adverse pregnancy outcomes: a population-basedstudy. Lancet 2006; 368: 1164-70.
7. Cnattingius S, Lambe M. Trends in smoking and over-weight during pregnancy: prevalence, risks of pregnancycomplications, and adverse pregnancy outcomes. Semin Per-inatol 2002; 4: 286-95.
8. Ahlenius I, Thomassen P. The changing panorama of late fetaldeath in Sweden between 1984 and 1991. Acta Obstet GynecolScand 1999; 5: 408-14.
9. Leonardi-Bee J, Britton J, Venn A. Secondhand smoke andadverse fetal outcomes in nonsmoking pregnant women: ameta-analysis. Pediatrics 2011; 127: 734-41.
10. Jacobsson B, Ladfors L, Milsom I. Advanced mater-nal age and adverse perinatal outcome. Obstet Gynecol2004; 104: 727-33.
11. Salihu HM, Wilson RE, Alio AP, Kirby RS. Advanced mater-nal age and risk of antepartum and intrapartum stillbirth. JObstet Gynaecol Res 2008; 34: 843-50.
12. Salihu HM, Sharma PP, Ekundayo OJ, Kristensen S, Badewa AP, Kirby RS, et al. Childhood pregnancy (10-14 years old)and risk of stillbirth in singletons and twins. J Pediatr2006; 148: 522-6.
13. Wilson RE, Alio AP, Kirby RS, Salihu HM. Young maternalage and risk of intrapartum stillbirth. Arch Gynecol Obstet2008; 278: 231-6.
14. Aliyu MH, Salihu HM, Keith LG, Ehiri JE, Islam MA, Jolly PE. Extreme parity and the risk of stillbirth. Obstet Gynecol2005; 106: 446-53.
15. Craig ED, Mantell CD, Ekeroma AJ, Stewart AW, Mitchell EA. Ethnicity and birth outcome: New Zealand trends 1980-2001. Part 1. Introduction, methods, results and overview. Aust N ZJ Obstet Gynaecol 2004; 44: 530-6.
16. Mohsin M, Bauman AE, Jalaludin B. The influence of ante-natal and maternal factors on stillbirths and neonataldeaths in New South Wales, Australia. J Biosoc Sci 2006; 38: 643-57.
17. Bech BH, Nohr EA, Vaeth M, Henriksen TB, Olsen J. Coffeeand fetal death: a cohort study with prospective data. Am JEpidemiol 2005; 162: 983-90.
18. Strandberg-Larsen K, Nielsen NR, Grønbaek M, Andersen PK, Olsen J, Andersen AM. Binge drinking in pregnancy and risk offetal death. Obstet Gynecol 2008; 111: 602-9.
19. Wingate MS, Alexander GR. Racial and ethnic differences inperinatal mortality: the role of fetal death. Ann Epidemiol2006; 16: 485-91.
20. Guendelman S, Chavez G, Christianson R. Fetal deaths inMexican-American, black, and white non-Hispanic womenseeking government-funded prenatal care. J CommunityHealth 1994; 19: 319-30.
21. Flenady V. Causes and risk factors of stillbirth in Australia. Perinatal Society of Australia and New Zealand Congress. Vol.44 Gold Coast. J Paediatr Child Health 2008: A2-10.
22. Surkan PJ, Stephansson O, Dickman PW, Cnattingius S. Pre-vious preterm and small-for-gestational-age births and thesubsequent risk of stillbirth. N Engl J Med 2004; 350: 777-85.
23. Salihu HM, Sharma PP, Aliyu MH. Is small for gestational agea marker of future fetal survival in utero? Obstet Gynecol2006; 107: 851-6.
24. McDonald SD, Vermeulen MJ, Ray JG. Risk of fetal deathassociated with maternal drug dependence and placentalabruption: a population-based study. J Obstet Gynaecol Can2007; 29: 556-9.
25. Salihu HM, Bekan B, Aliyu MH, Rouse DJ, Kirby RS, Alexander GR. Perinatal mortality associated with abruptioplacenta in singletons and multiples. Am J Obstet Gynecol2005; 193: 198-203.
26. Getahun D, Ananth CV, Kinzler WL. Risk factors for antepar-tum and intrapartum stillbirth: a population-based study. AmJ Obstet Gynecol 2007; 196: 499-507.
27. Dhont M, De Sutter P, Ruyssinck G, Martens G, Bekaert A. Per-inatal outcome of pregnancies after assisted reproduction: acase-control study. Am J Obstet Gynecol 1999; 181: 688-95.
28. Källén B, Finnström O, Nygren KG, Otterblad Olausson P, Wennerholm UB. In vitro fertilisation in Sweden: obste-tric characteristics, maternal morbidity and mortality. BJOG2005; 112: 1529-35.
29. Astolfi P, De Pasquale A, Zonta LA. Late paternity and stillbirthrisk. Hum Reprod 2004; 19: 2497-501.
30. Nybo Andersen AM, Hansen KD, Andersen PK, Davey Smith G. Advanced paternal age and risk of fetal death: a cohort study. Am J Epidemiol 2004; 160: 1214-22.
31. Mohsin M1, Bauman AE, Jalaludin B. The influence ofantenatal and maternal factors on stillbirths and neonataldeaths in New South Wales, Australia. J Biosoc Sci 2006; 38: 643-57.
32. Vintzileos AM, Ananth CV, Smulian JC, Scorza WE, Knuppel RA. The impact of prenatal care in the United States on pre-term births in the presence and absence of antenatal high-riskconditions. Am J Obstet Gynecol 2002; 187: 1254-7.
33. Reime B, Lindwedel U, Ertl KM, Jacob C, Schücking B, Wenzlaff P. Does underutilization of prenatal care explainthe excess risk for stillbirth among women with migra-tion background in Germany? Acta Obstet Gynecol Scand2009; 88: 1276-83.
34. Reddy UM, Goldenberg R, Silver R, Smith GC, Pauli RM, Wapner RJ, et al. Stillbirth classification-developing an inter-national consensus for research: executive summary of aNational Institute of Child Health and Human Developmentworkshop. Obstet Gynecol 2009; 114: 901-14.
35. Flenady V, Middleton P, Smith GC, Duke W, Erwich JJ, Khong TY, et al. Stillbirths: the way forward in high-incomecountries. Lancet's Stillbirths Series Steering Committee. Lancet 2011; 377: 1703-17.
36. Korteweg FJ, Gordijn SJ, Timmer A, Holm JP, Ravisé JM, Erwich JJ. A placental cause of intra-uterine fetal deathdepends on the perinatal mortality classification system used. Placenta 2008; 29: 71-80.
37. Kidron D, Bernheim J, Aviram R. Placental findings contribu-ting to fetal death, a study of 120 stillbirths between 23 and40 weeks gestation. Placenta 2009; 30: 700-4.
38. Pinar H, Goldenberg RL, Koch MA, Heim-Hall J, Hawkins HK, Shehata B, et al. Placental findings in singleton stillbirths. Obstet Gynecol 2014; 23: 325-36.
39. Stillbirth Collaborative Research Network Writing Group. Causes of death among stillbirths. JAMA 2011; 306: 2459-68.
40. Tantbirojn P, Saleemuddin A, Sirois K, Crum CP, Boyd TK, Two-Roger S, et al. Gross abnormalities of the umbilical cord: related placental histology and clinical significance. Placenta2009; 30: 1083-8.
41. Airas U, Heinonen S. Clinical significance of true umbi-lical knots: a population-based analysis. Am J Perinatol2002; 19: 127-32.
42. Carey JC, Rayburn WF. Nuchal cord encirclements and risk ofstillbirth. Int J Gynaecol Obstet 2000; 69: 173-4.
43. Rubod C, Deruelle P, Le Goueff F, Tunez V, Fournier M, Subtil D. Long-term prognosis for infants after massive feto-maternal hemorrhage. Obstet Gynecol 2007; 110: 256-60.
44. Korteweg FJ, Bouman K, Erwich JJ, Timmer A, Veeger NJ, Ravisé JM, et al. Cytogenetic analysis after evaluation of 750fetal deaths: proposal for diagnostic workup. Obstet Gynecol2008; 111: 865-74.
45. Wapner RJ, Lewis D. Genetics and metabolic causes of still-birth. Semin Perinatol 2002; 26: 70-4.
46. Won RH, Currier RJ, Lorey F, Towner DR. The timing of demisein fetuses with trisomy 21 and trisomy 18. Prenat Diagn2005; 25: 608-11.
47. Wapner RJ1, Simpson JL, Golbus MS, Zachary JM, Ledbetter DH, Desnick RJ, et al. Chorionic mosaicism: association with fetal loss but not with adverse perinataloutcome. Prenat Diagn 1992; 12: 347-55.
48. Baffero GM1, Somigliana E, Crovetto F, Paffoni A, Persico N, Guerneri S, et al. Confined placental mosaicism at chorionicvillous sampling: risk factors and pregnancy outcome. PrenatDiagn 2012; 32: 1102-8.
49. Reddy UM, Page GP, Saade GR, Silver RM, Thorsten VR, Parker CB, et al. Karyotype versus microarray testingfor genetic abnormalities after stillbirth. N Engl J Med2012; 367: 2185-93.
50. Goldenberg RL, McClure EM, Saleem S, Reddy UM. Infection-related stillbirths. Lancet 2010; 375: 1482-90.
51. Copper RL, Goldenberg RL, DuBard MB, Davis RO. Risk factorsfor fetal death in white, black, and Hispanic women. ObstetGynecol 1994; 84: 490-5.
52. Williams EJ, Embleton ND, Clark JE, Bythell M, Ward Platt MP, Berrington JE. Viral infections: contributions to late fetaldeath, stillbirth, and infant death. J Pediatr 2013; 163: 424-8.
53. Skjöldebrand-Sparre L, Tolfvenstam T, Papadogiannakis N, Wahren B, Broliden K, Nyman M. Parvovirus B19 infection: association with third-trimester intrauterine fetal death. BJOG 2000; 107: 476-80.
54. Tolfvenstam T1, Papadogiannakis N, Norbeck O, Petersson K, Broliden K. Frequency of human parvovirus B19 infection inintrauterine fetal death. Lancet 2001; 357: 1494-7.
55. Griffiths PD, Baboonian C. A prospective study of primarycytomegalovirus infection during pregnancy: final report. BrJ Obstet Gynaecol 1984; 91: 307-15.
56. Picone O, Vauloup-Fellous C, Cordier AG, Guitton S, Senat MV, Fuchs F, et al. A series of 238 cytomegalovirus primary infec-tions during pregnancy: description and outcome. PrenatDiagn 2013; 33: 751-8.
57. Becroft DM, Farmer K, Mason GH, Morris MC, Stewart JH. Per-inatal infections by group B beta-haemolytic streptococci. BrJ Obstet Gynaecol 1976; 83: 960-6.
58. Christensen KK, Christensen P, Hägerstrand I, Lindén V, Nordbring F, Svenningsen N. The clinical significance of groupB streptococci. J Perinat Med 1982; 10: 133-46.
59. Collins S, Ramsay M, Slack MP, Campbell H, Flynn S, Litt D, et al. Risk of invasive Haemophilus influenzae infection duringpregnancy and association with adverse fetal outcomes. JAMA2014; 311: 1125-32.
60. Thorp Jr JM, Katz VL, Fowler LJ, Kurtzman JT, Bowes Jr WA. Fetal death from chlamydial infection across intact amnioticmembranes. Am J Obstet Gynecol 1989; 161: 1245-6.
61. Galask RP, Varner MW, Petzold CR, Wilbur SL. Bacterial attach-ment to the chorioamniotic membranes. Am J Obstet Gynecol1984; 148: 915-28.
62. Smith B, Kemp M, Ethelberg S, Schiellerup P, Bruun BG, Gerner-Smidt P, et al. Listeria monocytogenes: maternal-foetal infections in Denmark 1994-2005. Scand J Infect Dis2009; 41: 21-5.
63. Li XL, Wei HX, Zhang H, Peng HJ, Lindsay DS. A meta analysison risks of adverse pregnancy outcomes in Toxoplasma gondiiinfectio. PLoS One 2014; 9: e97775.
64. Pauli RM, Reiser CA. Wisconsin Stillbirth Service Program: II. Analysis of diagnoses and diagnostic categories in the first1, 000 referrals. Am J Med Genet 1994; 50: 135-53.
65. Peticca P, Keely EJ, Walker MC, Yang Q, Bottomley J. Pre-gnancy outcomes in diabetes subtypes: how do they compare?A province-based study of Ontario, 2005-2006. J ObstetGynaecol Can 2009; 31: 487-96.
66. Nizard J, Guettrot-Imbert G, Plu-Bureau G, Ciangura C, Jacqueminet S, Leenhardt L, et al. Pathologies mater-nelles chroniques et pertes de grossesse. Recommanda-tions françaises. J Gynecol Obstet Biol Reprod 2014, http://dx.doi.org/10.1016/j.jgyn.2014.09.017.
67. Gardosi J, Kady SM, McGeown P, Francis A, Tonks A. Classifi-cation of stillbirth by relevant condition at death (ReCoDe): population based cohort study. BMJ 2005; 331: 1113-20.
68. Chan A, King JF, Flenady V, Haslam RH, Tudehope DI. Classi-fication of perinatal deaths: development of the Australianand New Zealand classifications. J Paediatr Child Health2004; 40: 340-7.
69. Korteweg FJ, Gordijn S, Timmer A, Erwich J, Bergman K, Bouman K, et al. The Tulip classification of perina-tal mortality: introduction and multidisciplinary inter-rateragreement. BJOG 2006; 113: 393-401.
70. Cole SK, Hey EN, Thomson AM. Classifying perinatal death: anobstetric approach. Br J Obstet Gynaecol 1986; 93: 1204-10.
71. CESDI. Confidential Enquiry into Stillbirths and Deaths inInfancy: 8th Annual Report. London: Maternal and ChildHealth Research Consortium; 2001.
72. Frøen JF, Pinar H, Flenady V. Integrating the purposes of stil-lbirth classifications. In: 2006 International Stillbirth AllianceConference in collaboration with 9th SIDS International Confe-rence. 2006.
73. Vergani P, Cozzolino S, Pozzi E, Cuttin MS, Greco M, Ornaghi S, et al. Identifying the causes of stillbirth: a com-parison of four classification systems. Am J Obstet Gynecol2008; 199, 319.e1-4.
74. Lu JR, McCowan L. A comparison of the Perinatal Society ofAustralia and New Zealand-Perinatal Death Classification sys-tem and relevant condition at death stillbirth classificationsystems. Aust N Z J Obstet Gynaecol 2009; 49: 467-71.
75. Flenady V, Frøen JF, Pinar H, Torabi R, Saastad E, Guyon G, et al. An evaluation of classification systems for stillbirth. BMCPregnancy Childbirth 2009; 9: 24.
76. Helgadóttir LB, Turowski G, Skjeldestad FE, Jacobsen AF, Sandset PM, Roald B, et al. Classification of stillbirths and riskfactors by cause of death-a case-control study. Acta ObstetGynecol Scand 2013; 92: 325-33.
77. Bukowski R, Carpenter M, Conway D, Coustan D, Dudley DJ, Goldenberg RL, et al. Causes of death among stillbirths. JAMAJ Am Med Assoc 2011; 306: 2459-68.
78. Korteweg FJ, Erwich JJHM, Timmer A, van der Meer J, Ravisé JM, Veeger NJGM, et al. Evaluation of 1025 fetaldeaths: proposed diagnostic workup. Am J Obstet Gynecol2012; 206, 53. e1-53.e12.
79. Corabian P, Scott A, Alberta Heritage Foundation for Medi-cal Research. Protocols for stillbirth investigation [Internet]. Edmonton, Alta.: Alberta Heritage Foundation for Medi-cal Research; 2005 [cited 2014 Jan 15]. Available from: http://site.ebrary.com/id/10104170
80. Gordijn SJ, Korteweg FJ, Erwich JJ, Holm JP, van Diem MT, Bergman KA, et al. A multilayered approach for the analysisof perinatal mortality using different classification systems. Eur J Obstet Gynecol Reprod Biol 2009; 144: 99-104.
81. Roescher AM, Timmer A, Erwich JJHM, Bos AF. Placentalpathology, perinatal death, neonatal outcome, and neu-rological development: A systematic review. PLoS ONE2014; 9: e89419.
82. Hickey L, Murphy A, Devaney D, Gillan J, Clarke T. The valueof neonatal autopsy. Neonatology 2012; 101: 68-73.
83. Flenady V, Middleton P, Smith GC, Duke W, Erwich JJ, Khong TY, et al. Stillbirths: the way forward in high-income coun-tries. Lancet 2011; 377: 1703-17.
84. Shepperd S, Lewin S, Straus S, Clarke M, Eccles MP, Fitzpatrick R, et al. Can we systematically review studies that evaluatecomplex interventions? PLoS Med 2009; 6: e1000086.
85. Ergina PL, Cook JA, Blazeby JM, Boutron I, Clavien P.-A., Reeves BC, et al. Challenges in evaluating surgical innovation. TheLancet 2009; 374: 1097-104.
86. Thayyil S, Chandrasekaran M, Chitty LS, Wade A, Skordis-Worrall J, Bennett-Britton I, et al. Diagnostic accuracy ofpost-mortem magnetic resonance imaging in fetuses, chil-dren and adults: a systematic review. Eur J Radiol 2010; 75, e142-8.
87. Thayyil S1, Sebire NJ, Chitty LS, Wade A, Chong W, Olsen O, et al. MRI versus conventional autopsy in fetuses and children: a prospective validation study. Lancet 2013; 382: 223-33.
88. Thayyil S1, Cleary JO, Sebire NJ, Scott RJ, Chong K, Gunny R, et al. Post-mortem examination of human fetuses: a compa-rison of whole-body high-field MRI at 9.4 T with conventionalMRI and invasive autopsy. Lancet 2009; 374, 467-75.d.
89. Radestad I, Surkan PJ, Steineck G, Cnattingius S, Onelöv E, Dickman PW. Long-term outcomes for mothers who haveor have not held their stillborn baby. Midwifery 2009; 25: 422-9.
90. ACOG. Practice Bulletin No. 102: management of stillbirth. Obstet Gynecol 2009; 113: 748-61.
91. http://www.rcog.org.uk/womens-health/clinical-guidance/late-intrauterine-fetal-death-and-stillbirth-green-top-55
92. Pattinson R, Kerber K, Buchmann E, Friberg IK, Belizan M, Lansky S, et al. Stillbirths: how can health systems deliverfor mothers and babies? Lancet's Stillbirths Series steeringcommittee. Lancet 2011; 377: 1610-23.
93. Bhutta ZA, Yakoob MY, Lawn JE, Rizvi A, Friberg IK, Weissman E, et al. Stillbirths: what difference can we make and at whatcost? Lancet's Stillbirths Series steering committee. Lancet2011; 377: 1523-38.
94. Temel S, van Voorst SF, Jack BW, Denktaş S, Steegers EA. Evidence-based preconceptional lifestyle interventions. Epi-demiol Rev 2014; 36: 19-30.
95. De-Regil LM, Fernández-Gaxiola AC, Dowswell T, Peña-Rosas JP. Effects and safety of periconcep-tional folate supplementation for preventing birthdefects. Cochrane Database Syst Rev 2010: CD007950, http://dx.doi.org/10.1002/14651858.CD007950.pub2.
96. Reveiz L, Gyte GM, Cuervo LG. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev2007: CD003094.
97. Pena-Rosas JP, Viteri FE. Effects of routine oral iron sup-plementation with or without folic acid for women duringpregnancy. Cochrane Database Syst Rev 2006: CD004736.
98. Makrides M, Crowther CA. Magnesium supplementation in pre-gnancy. Cochrane Database Syst Rev 2001: CD000937.
99. Rumbold A, Middleton P, Crowther CA. Vitamin supplementa-tion for preventing miscarriage. Cochrane Database Syst Rev2005: CD004073.
100. Lumley J, Oliver SS, Chamberlain C, Oakley L. Interventionsfor promoting smoking cessation during pregnancy. CochraneDatabase Syst Rev 2004: CD001055.
101. Carroli G, Villar J, Piaggio G, Khan-Neelofur D, Gülmezoglu M, Mugford M, et al. WHO systematic review of rando-mised controlled trials of routine antenatal care. Lancet2001; 357: 1565-70.
102. Villar J, Carroli G, Khan-Neelofur D, Piaggio G, Gülmezoglu M. Patterns of routine antenatal care for low-risk pregnancy. Cochrane Database Syst Rev 2001: CD000934.
103. Mangesi L, Hofmeyr GJ. Fetal movement counting forassessment of fetal wellbeing. Cochrane Database Syst Rev2007: CD004909.
104. Hodnett ED, Fredericks S. Support during pregnancy forwomen at increased risk of low birthweight babies. CochraneDatabase Syst Rev 2003: CD000198.
105. Bricker L, Neilson JP, Dowswell T. Routine ultrasound in latepregnancy (after 24 weeks' gestation). Cochrane DatabaseSyst Rev 2008: CD001451.
106. Haws RA, Yakoob MY, Soomro T, Menezes EV, Darmstadt GL, Bhutta ZA. Reducing stillbirths: screening and monito-ring during pregnancy and labour. BMC Pregnancy Childbirth2009; 9: S5.
107. Subtil D, Goeusse P, Houfflin-Debarge V, Puech F, Lequien P, Breart G, et al. Randomised comparison of uterine artery dop-pler and aspirin (100 mg) with placebo in nulliparous women: the Essai régional aspirine mère-enfant study (part 2). BJOG2003; 110: 485-91.
108. Baschat AA, Gembruch U, Weiner CP, Harman CR. Qualita-tive venous doppler waveform analysis improves predictionof critical perinatal outcomes in premature growth-restrictedfetuses. Ultrasound Obstet Gynecol 2003; 22: 240-5.
109. Baschat AA. Doppler application in the delivery timing of thepreterm growth-restricted fetus: another step in the rightdirection. Ultrasound Obstet Gynecol 2004; 23: 111-8.
110. Hofmeyr GJ, Atallah AN, Duley L. Calcium supplementa-tion during pregnancy for preventing hypertensive disor-ders and related problems. Cochrane Database Syst Rev2006: CD001059.
111. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Antihypertensive drug therapy for mild to moderate hyper-tension during pregnancy. Cochrane Database Syst Rev2007: CD002252.
112. Duley L, Henderson-Smart DJ, Meher S. Drugs for treatmentof very high blood pressure during pregnancy. Cochrane Data-base Syst Rev 2006: CD001449.
113. Askie LM, Duley L, Henderson-Smart DJ, Stewart LA, PARISCollaborative Group. Antiplatelet agents for prevention ofpre-eclampsia: a meta-analysis of individual patient data. Lancet 2007; 369: 1791-8.
114. Rumbold A, Duley L, Crowther CA, Haslam RR. Antioxidantsfor preventing pre-eclampsia. Cochrane Database Syst Rev2008: CD004227.
115. Robson S, Thompson J, Ellwood D. Obstetric management ofthe next pregnancy after an unexplained stillbirth: an ano-nymous postal survey of Australian obstetricians. Aust N Z JObstet Gynaecol 2006; 46: 278-81.
116. Robson SJ, Leader LR, Bennett MJ, Dear KB. Do women's perceptions of care at the time ofunexplained stillbirth influence their wishes for mana-gement in subsequent pregnancy? An Internet-basedempirical study. J Obstet Gynaecol Res 2010; 36: 108-14, http://dx.doi.org/10.1111/j.1447-0756.2009.01113.x.
117. Spitz AM, Lee NC, Peterson HB. Treatment for lactation sup-pression: little progress in one hundred years. Am J ObstetGynecol 1998; 179: 1485-90.
118. Oladapo OT, Fawole B. Treatments for suppression of lacta-tion. Cochrane Database Syst Rev 2009: CD005937.
119. Almeida Jr OD, Kitay DZ. Lactation suppression and puerperalfever. Am J Obstet Gynecol 1986; 154: 940-1.
120. Melis GB, Mais V, Paoletti AM, Beneventi F, Gambacciani M, Fioretti P. Prevention of puerperal lactation by a single oraladministration of the new prolactin-inhibiting drug, cabergo-line. Obstet Gynecol 1988; 71: 311-4.
121. Bravo-Topete EG, Mendoza-Hernández F, Cejudo-Alvarez J, Briones-Garduño C. [Cabergoline for inhibition of lactation]. Cir Cir 2004; 72: 5-9.
122. Venturini PL, Horowski R, Maganza C, Morano S, Pedretti E, Ragni N, et al. Effects of lisuride and bromocriptine oninhibition of lactation and on serum prolactin levels: compa-rative double-blind study. Eur J Obstet Gynecol Reprod Biol1981; 11: 395-400.
123. WHO. Neonatal and perinatal mortality for the year 2000: country, regional and global estimates. Geneva: World HealthOrganization; 2006.
124. Compte-rendu [Internet]. [cited 2014 Jan 15]. Available from: http://ansm.sante.fr/content/download/51361/662259/version/1/file/CRCom-Suivi30-04-2013-.pdfCommissiondesuividurapportbeneficerisquedesproduitsdesanteno2; 2013.
125. http://ansm.sante.fr/S-informer/Points-d-information-Points-dinformation/Bromocriptine-Parlodel-R-et-Bromocriptine-Zentiva-R-le-rapport-benefice-risque-n-est-plus-favorable-dans-l-inhibition-de-la-lactation-Point-d-information.